Cf. Pilati et al., PERSISTENT LEFT-VENTRICULAR DYSFUNCTION AFTER COCAINE TREATMENT IN RABBITS, Proceedings of the Society for Experimental Biology and Medicine, 203(1), 1993, pp. 100-107
The present study was undertaken to determine whether the diminished c
ardiac performance associated with cocaine administration persists aft
er the drug has been eliminated from the body. Cocaine (5 or 10 mg/kg
iv) was administered to conscious (n = 7) or pentobarbital-anesthetize
d (n = 7) rabbits, respectively. Seven conscious and seven anesthetize
d control rabbits received the saline vehicle. Two and one-half hours
later, the hearts were removed from the animals and perfused under coc
aine-free conditions. Left ventricular (LV) contractility was evaluate
d by plotting steady-state LV systolic and diastolic pressures as a fu
nction of LV end-diastolic volume (preload). LV systolic performance w
as diminished in a dose-related manner in hearts isolated from cocaine
-treated rabbits, but was statistically different from control only at
the higher cocaine dose (P < 0.05). In a second set of experiments, h
earts (n = 6) were isolated, and their LV function was evaluated befor
e, during, and after cocaine exposure. In these experiments, cocaine w
as added to the perfusate in increments to produce concentrations of 5
, 10, and 15 mg/liter. After LV function was evaluated at the highest
cocaine dose, cocaine-free perfusion conditions were restored, and LV
function was reevaluated. In these experiments, cocaine produced a dos
e-dependent decrease in LV function that readily reversed when cocaine
-free perfusion was reinstated. We conclude that cocaine diminishes LV
contractility, and that the diminished cardiac performance may not re
adily reverse after in vivo exposure. Moreover, the rapid restoration
of cardiac performance after exposure to cocaine in vitro suggests tha
t the mechanism operating in vivo involves more than a simple direct a
ction on the myocyte. Catecholamine cardiotoxicity does not appear to
be a primary factor.